Market Overview:
The global drug discovery market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising R&D expenditure by pharmaceutical and biotechnology companies, and the increasing number of approvals for novel drugs. The small molecule drug segment is expected to dominate the global drug discovery market during the forecast period. This segment is projected to grow at a CAGR of 11% from 2018 to 2030. The growth in this segment can be attributed to the growing demand for small molecule drugs owing to their high efficacy and safety profiles compared with biologics drugs. The research institutes segment is expected to dominate the global drug discovery market during the forecast period. This segment accounted for a share of 43% in 2017 and is projected grow at a CAGR of 11%.
Product Definition:
The process of drug discovery is the process of finding new drugs to treat diseases. The importance of drug discovery is that it helps find new treatments for diseases.
Small Molecule Drug:
Small molecule drugs are the most commonly used pharmaceutical products. They account for a large share of the total pharmaceutical market and have been witnessing steady growth over recent years. This is mainly due to technological advancements in molecular biology, which has led to an increase in the number of small molecule drugs available for use.
Biologics Drug:
Biologics drug is a drug derived from living organisms and used for the treatment of diseases. It's major application is in the field of oncology, neurology, autoimmune disease treatment & transplantation. Biologics drugs are different from conventional small molecule drugs as they are made up of unique molecules that help cure diseases with fewer side effects.
The global biologics market size was valued at USD 279 billion in 2015.
Application Insights:
Based on application, the global drug discovery market has been segmented into research institutes, pharmaceutical companies and biotechnology companies. Research institutes held the largest share of over 60% in 2017. This is attributed to presence of a large number of academic institutions involved in R&D for various therapeutic areas across the globe. Moreover, many public and private organizations also support drug discovery research at Institutes level which further contributes to segment growth.
Pharmaceutical companies are anticipated to witness significant growth during forecast period owing to increasing product launch by major players in order to generate higher revenue streams from existing products as well as gain new customers among other drugs developed by them or through them. For instance, Pfizer Inc., one of America's largest pharmaceutical companies has entered into an agreement with Allergan Plc under which Pfizer will receive financial incentives if it launches any new drugs that are similar or identical to those developed by Allergan Plc since 2013 (excluding Botox).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and small molecule drug discovery companies coupled with high R&D investment by the U.S.-based pharmaceutical companies is expected to drive this regional market over the forecast period. Asia Pacific is estimated to be one of the fastest-growing regions during 2018’s forecast period owing to increasing focus on developing novel therapies for unmet medical needs in emerging countries, such as China and India. Moreover, an increase in government funding for basic research on target diseases will also boost regional growth over the coming years (Ref.).
The Latin American region comprises several emerging markets with growing economies, such as Brazil and Mexico; however, they lack proper infrastructure required for conducting efficient drug discovery processes due to which there are fewer biopharmaceutical firms present compared to developed nations (Ref.).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The increase in the number of people suffering from chronic diseases has led to a corresponding increase in the demand for drugs and therapies for their treatment. This is providing a major growth driver for the drug discovery market.
- Advances in technology: The field of drug discovery is constantly evolving due to advances in technology. This has led to the development of new and more effective drugs and therapies, which are helping to treat a wider range of illnesses. This is another major growth driver for the drug discovery market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Discovery Market Research Report
By Type
Small Molecule Drug, Biologics Drug
By Application
Research Institutes, Pharmaceutical Companies, Biotechnology Companies
By Companies
Pfizer, GSK, Merck, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Drug Discovery Market Report Segments:
The global Drug Discovery market is segmented on the basis of:
Types
Small Molecule Drug, Biologics Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutes, Pharmaceutical Companies, Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GSK
- Merck
- Agilent
- Eli Lilly and Company
- Roche
- Bayer
- Abbott
- AstraZeneca
- Shimadzu
Highlights of The Drug Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecule Drug
- Biologics Drug
- By Application:
- Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug discovery is the process of identifying new drugs and developing them into therapies. Drug discovery can be divided into two main phases: preclinical drug development and clinical drug development.
Some of the major players in the drug discovery market are Pfizer, GSK, Merck, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu.
The drug discovery market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Discovery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Discovery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Discovery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Discovery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Discovery Market Size & Forecast, 2020-2028
4.5.1 Drug Discovery Market Size and Y-o-Y Growth
4.5.2 Drug Discovery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Small Molecule Drug
5.2.2 Biologics Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Institutes
6.2.2 Pharmaceutical Companies
6.2.3 Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Discovery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Discovery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Small Molecule Drug
9.6.2 Biologics Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Institutes
9.10.2 Pharmaceutical Companies
9.10.3 Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Small Molecule Drug
10.6.2 Biologics Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Institutes
10.10.2 Pharmaceutical Companies
10.10.3 Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Small Molecule Drug
11.6.2 Biologics Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Institutes
11.10.2 Pharmaceutical Companies
11.10.3 Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Small Molecule Drug
12.6.2 Biologics Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Institutes
12.10.2 Pharmaceutical Companies
12.10.3 Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Small Molecule Drug
13.6.2 Biologics Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Institutes
13.10.2 Pharmaceutical Companies
13.10.3 Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Discovery Market: Competitive Dashboard
14.2 Global Drug Discovery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GSK
14.3.3 Merck
14.3.4 Agilent
14.3.5 Eli Lilly and Company
14.3.6 Roche
14.3.7 Bayer
14.3.8 Abbott
14.3.9 AstraZeneca
14.3.10 Shimadzu
